Bellevue Group Ag Neogenomics Inc Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Neogenomics Inc stock. As of the latest transaction made, Bellevue Group Ag holds 1,612,612 shares of NEO stock, worth $26.5 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

1,612,612

Previous 1,202,096 34.15%

Holding current value

$26.5 Million

Previous $16.7 Million 42.66%

% of portfolio

0.4%

Previous 0.28%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $5.5 Million - $7.28 Million	410,516 Added 34.15%	1,612,612 $23.8 Million
Q2 2024 Aug 14, 2024	BUY	$13.01 - $15.77 $3.33 Million - $4.04 Million	256,071 Added 27.07%	1,202,096 $16.7 Million
Q1 2024 May 15, 2024	BUY	$14.06 - $16.79 $13.3 Million - $15.9 Million	946,025 New	946,025 $14.9 Million
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $5.71 Million - $16.6 Million	-469,695 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$30.49 - $48.49 $2.8 Million - $4.46 Million	-91,988 Reduced 16.38%	469,695 $16 Million
Q3 2021 Nov 12, 2021	SELL	$41.66 - $52.52 $10.7 Million - $13.5 Million	-256,630 Reduced 31.36%	561,683 $27.1 Million
Q2 2021 Aug 12, 2021	BUY	$36.62 - $51.69 $1.11 Million - $1.57 Million	30,360 Added 3.85%	818,313 $37 Million
Q1 2021 May 12, 2021	BUY	$41.56 - $59.88 $9.95 Million - $14.3 Million	239,507 Added 43.67%	787,953 $38 Million
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $4.39 Million - $6.86 Million	121,554 Added 28.47%	548,446 $29.5 Million
Q3 2020 Nov 16, 2020	SELL	$33.26 - $40.48 $1.95 Million - $2.37 Million	-58,578 Reduced 12.07%	426,892 $15.7 Million
Q2 2020 Aug 13, 2020	BUY	$24.21 - $31.02 $11.8 Million - $15.1 Million	485,470 New	485,470 $15 Million

Others Institutions Holding NEO

# of Institutions

294

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Neogenomics Inc Transaction History